Clinical development of Modified Vaccinia virus Ankara vaccines.

Clinical development of Modified Vaccinia virus Ankara vaccines.

Show other versions (1)

The smallpox vaccine Vaccinia was successfully used to eradicate smallpox, but although very effective, it was a very reactogenic vaccine and responsible for the deaths of one or two people per million vaccinated. Modified Vaccinia virus Ankara (MVA) is a replication-deficient and attenuated derivat...

תיאור מלא

מידע ביבליוגרפי
מחבר ראשי:	Gilbert, S
פורמט:	Journal article
שפה:	English
יצא לאור:	2013

פריטים דומים

Clinical development of Modified Vaccinia virus Ankara vaccines
מאת: Gilbert, S
יצא לאור: (2013)

Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
מאת: Olga Vladimirovna Orlova, et al.
יצא לאור: (2022-09-01)

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
מאת: Gilbert, S, et al.
יצא לאור: (1999)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
מאת: Moorthy, V, et al.
יצא לאור: (2003)

Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer
מאת: Kaïdre Bendjama, et al.
יצא לאור: (2017-09-01)

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
מאת: Volker Sandig, et al.
יצא לאור: (2013-11-01)

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
מאת: Juan García-Arriaza, et al.
יצא לאור: (2021-08-01)

Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans
מאת: Alina Tscherne, et al.
יצא לאור: (2024-11-01)

Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
מאת: López-Camacho, C, et al.
יצא לאור: (2019)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
מאת: Alharbi, N
יצא לאור: (2014)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
מאת: César López-Camacho, et al.
יצא לאור: (2019-11-01)

Improved Host Range Selection for Recombinant Modified Vaccinia Virus Ankara
מאת: Caroline Staib, et al.
יצא לאור: (2003-04-01)

Ebola virus – prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine
מאת: Harriet L. Robinson, et al.
יצא לאור: (2018-09-01)

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
מאת: McConkey, S, et al.
יצא לאור: (2003)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
מאת: Rosario, M, et al.
יצא לאור: (2010)

Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus
מאת: Flavia Chiuppesi, et al.
יצא לאור: (2024-02-01)

The third generation modified vaccinia Ankara vaccine is effective in preventing the transmission of mpox
מאת: Mingwang Shen, et al.
יצא לאור: (2024-10-01)

Deletion of fifteen open reading frames from modified vaccinia virus Ankara fails to improve immunogenicity
מאת: Alharbi, N, et al.
יצא לאור: (2015)

Transient Host Range Selection for Genetic Engineering of Modified Vaccinia Virus Ankara
מאת: C. Staib, et al.
יצא לאור: (2000-06-01)

Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
מאת: Malachy I. Okeke, et al.
יצא לאור: (2017-10-01)

Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity.
מאת: Naif Khalaf Alharbi, et al.
יצא לאור: (2015-01-01)

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.
מאת: Moorthy, V, et al.
יצא לאור: (2003)

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers
מאת: Moorthy, V, et al.
יצא לאור: (2003)

Cardiac Safety in Clinical Trials with Preventive HIV Vaccine Candidates Based on Modified Vaccinia Ankara (MVA)
מאת: Schmidt, C, et al.
יצא לאור: (2008)

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.
מאת: Behboudi, S, et al.
יצא לאור: (2004)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
מאת: Schneider, J, et al.
יצא לאור: (1998)

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
מאת: Dorrell, L, et al.
יצא לאור: (2000)

Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara
מאת: Nereida Jiménez de Oya, et al.
יצא לאור: (2022-03-01)

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
מאת: Hanke, T, et al.
יצא לאור: (1998)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
מאת: Cottingham, M, et al.
יצא לאור: (2008)

Genome Sequencing of a Camelpox Vaccine Reveals Close Similarity to Modified <i>Vaccinia virus</i> Ankara (MVA)
מאת: Maurilia Marcacci, et al.
יצא לאור: (2020-07-01)

Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant
מאת: Ning Yang, et al.
יצא לאור: (2022-10-01)

Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara-vectored ebola vaccines at 1 year
מאת: Winslow, R, et al.
יצא לאור: (2017)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
מאת: Matthew G Cottingham, et al.
יצא לאור: (2008-02-01)

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
מאת: David A Garber, et al.
יצא לאור: (2009-01-01)

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
מאת: Goepfert P, et al.
יצא לאור: (2012-09-01)

Therapeutic vaccination against hepatitis B virus using heterolgous prime boost strategy with DNA and modified vaccinia virus ankara vectors
מאת: McConkey, S, et al.
יצא לאור: (2003)

Modified vaccinia virus Ankara exerts potent immune modulatory activities in a murine model.
מאת: Miriam Nörder, et al.
יצא לאור: (2010-01-01)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
מאת: Mcshane, H, et al.
יצא לאור: (2001)

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.
מאת: Hanke, T, et al.
יצא לאור: (2007)